[G24-11] Elranatamab (multiple myeloma) - Addendum to Project A24-12
Last updated 18.07.2024
Project no.:
G24-11
Commission:
Commission awarded on 28.05.2024 by the Federal Joint Committee (G-BA).
Report type:
Addendum
Status:
Commission completed
Department/Division:
Health Economics
Topic:
Cancer
Note:
If, in the course of the discussions on a commission of the G-BA, a need for further revision arises, IQWiG presents its report in the form of an addendum. The G-BA decides on the number of patients in the SHI target population.
DOI:
https://doi.org/10.60584/G24-11
| Project no. | Title | Status |
|---|---|---|
| A24-12 | Elranatamab (multiple myeloma) – Benefit assessment according to §35a Social Code Book V | Commission completed |
Federal Joint Committee (G-BA)
2024-07-18 A G-BA decision was published.